CMTM6 and pancreatic adenocarcinoma: Considering that CMTM6 is expressed is upregulated within PAAD and its elevated expression indicates a worse estimated outcome of PAAD patients, to further research the biological function of CMTM6, we carried out a loss-of-function experiment.